Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb trial of Revamilast in methotrexate-inadequate responder rheumatoid arthritis
2011-000107-40Phase 2Completed
- Sponsor
- Glenmark Pharmaceuticals SA
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of revamilast in rheumatoid arthritis (RA) (4 arms), sponsored by Glenmark Pharmaceuticals SA. Primary endpoint: Primary efficacy assessment. Started Mar 2011; status: completed.
02
Drugs
revamilast
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-000107-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000107-40.